Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL951223

O=C(O)C(F)(F)F.O=C(O)CCNCCCc1cccc(OCc2cccc(Oc3ccccc3)c2)c1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 10/20 0.59
FFAR4 Q5NUL3 3/20 0.59
S1PR1 P21453 4/20 0.52
S1PR3 Q99500 2/20 0.52
BCHE P06276 1/20 0.51
S1PR5 Q9H228 1/20 0.50
LTA4H P09960 1/20 0.47
FDFT1 P37268 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL948242 0.94 FFAR1 (0.69) FFAR1FFAR4S1PR1S1PR3S1PR5
Trifluoroacetic Acid SCHEMBL946822 0.94 FFAR1 (0.61) FFAR1FFAR4BCHE
Trifluoroacetic Acid SCHEMBL950036 0.94 BCHE (0.58) FFAR1FFAR4S1PR1S1PR3BCHE
SCHEMBL15890952 0.94 FFAR1 (0.63) FFAR1FFAR4S1PR1S1PR3BCHE
Trifluoroacetic Acid SCHEMBL947794 0.89 FFAR1 (0.60) FFAR1FFAR4BCHE
Trifluoroacetic Acid SCHEMBL946544 0.88 S1PR1 (0.71) FFAR1FFAR4S1PR1S1PR3S1PR5
Trifluoroacetic Acid SCHEMBL946349 0.88 FFAR1 (0.72) FFAR1FFAR4S1PR1S1PR3
Trifluoroacetic Acid SCHEMBL949625 0.87 S1PR1 (0.69) FFAR1S1PR1S1PR3BCHES1PR5
Trifluoroacetic Acid SCHEMBL948865 0.87 S1PR1 (0.65) FFAR1S1PR1S1PR3S1PR5LTA4H
SCHEMBL15891039 0.87 FFAR1 (0.74) FFAR1FFAR4S1PR1S1PR3BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2883865-A1 Compound capable of binding S1P receptor and pharmaceutical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2015-06-17 EP disclosed
US-20140288034-A1 COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2014-09-25 US disclosed
US-8791159-B2 Compound capable of binding S1P receptor and pharmaceutical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2014-07-29 US disclosed
US-20110020324-A1 COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD (JP) 2011-01-27 US disclosed
US-7825109-B2 Compound capable of binding S1P receptor and pharmaceutical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-11-02 US disclosed
US-20070167425-A1 Compound capable of binding s1p receptor and pharmaceutical use thereof ONO PHARMACEUTICAL CO., LTD (JP) 2007-07-19 US disclosed
EP-1661881-A2 COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288034-A1 COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF S1PR1, S1PR2, S1PR3 FFAR1 28/4885FFAR4 191/4885S1PR1 1/4885
US-20070167425-A1 Compound capable of binding s1p receptor and pharmaceutical use thereof S1PR1, S1PR3, S1PR2 FFAR1 37/4885FFAR4 267/4885S1PR1 1/4885
US-20110020324-A1 COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF S1PR1, S1PR3, S1PR2 FFAR1 37/4885FFAR4 267/4885S1PR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.